openPR Logo
Press release

India IVF Treatment Market Outlook 2018

06-29-2017 02:02 PM CET | Health & Medicine

Press release from: Kuick Resarch

India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer from infertility). Infertility or the inability to have children refers to a range of disorders some of which affect the male, and some the female, and contribute to childlessness in a couple. There is also something called unexplained infertility, where doctors are unable to provide a medical explanation for the couple’s inability to conceive.

In India, approximately 15%-20% of married couple s in their fertile age group, suffer from infertility and it is on the increase because of urbanization, pollution, chemical exposure, stress, competitive work environment, fast-paced lifestyles, late settlement in life, more women opting to work, increased incidence of diabetes, pelvic inflammatory diseases, etc.Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction; endoscopic surgery to correct anatomical problems; and the assisted reproductive technologies, including IUI, IVF, and ICSI (intra cytoplasmic sperm injection).

Download Report:

https://www.kuickresearch.com/report-India-IVF-Treatment-Market-Outlook-2018.php

India has become one of the favored destinations for infertility treatments such as IVF due to several factors including its medical expertise, state-of-the-art technology (which is at par with the best in the world), and a cost-effective health care system.

“India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India:

* Market Overview
* IVF Treatment Market Potential
* Total Fertility Rate Profile
* Emerging Trends
* The Assisted Reproductive Technology (Regulation) Bill 2010
* Competitive Landscape

For Report Sample Contact: neeraj@kuickresearch.com or

visit: https://www.kuickresearch.com

Recent Publications:

* Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
* Global CAR T Cell Therapy Market & Clinical Trials Insight 2022
* Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023
* Global Microcapsules Drug Delivery Market Opportunity Outlook 2022
* Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022
* Global Cancer Antibody Drug Conjugates Market & Pipeline Insight 2022
* Global B Cell Lymphoma Market & Clinical Pipeline Insight 2022

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release India IVF Treatment Market Outlook 2018 here

News-ID: 602350 • Views: 299

More Releases from Kuick Resarch

Global CFTR Modulators Market Opportunity Clinical Trials Insight 2026
“Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026” Report Highlights: • Global CFTR Modulators Market Opportunity: > US$ 20 Billion • Global CFTR Modulators Market Growth: 42% CAGR (2017 -2020) • Global CFTR Modulators Market Growth In 2020: 55% • Global CFTR Modulators Pipeline: 30 Drug • Commercially Available Bispecific Antibodies: 4 Drugs • Trikafta Market Share 2020: > 50% Download Report: https://www.kuickresearch.com/report-global-cystic-fibrosis-cftr-modulators-therapeutics-market-size-vertex-trikafta-cftr-potentiators-clinical-trials-research “Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026” provides
Gamma Delta T Cell Cancer Therapy Opportunity Clinical Trials Insight 2026
“Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” Report Highlights: • Commercialization Market Potential After Market Launch: > USD 4 Billion • Insight on Key Drugs In Research & Development • Global Gamma Delta T Cell Cancer Therapy Clinical Trials Insight • Gamma Delta T Cell Cancer Therapy In clinical Trials: > 15 Therapies • Gamma Delta T Cell Cancer Therapy Market Opportunity By Cancer Type • Adopted Approaches for Gamma Delta T Cell Therapy Download
Global Peptide Drug Conjugate Clinical Trial Report 2026
Global Peptide Drug Conjugate Market & Clinical Trials Insight 2026 Report Highlights: • First FDA Approved Peptide Drug Conjugate: Pepaxto (Melphalan Flufenamide) • Pepaxto Clinical & Commercial Insight: Dosage, Patent, Price, Sales Forecast • Peptide Drug Conjugate Sales Opportunity: US, Europe, Japan & South Korea • Global Peptide Drug Conjugate Clinical Pipeline: > 20 Drugs • Clinical Trials Insight by Company, Country, Indication • Patent Insight of Peptide Drug Conjugates • Profile & Clinical Pipeline Insight of Companies Developing Peptide Drug Conjugates Download Report: https://www.kuickresearch.com/report-global-peptide-drug-conjugate-antibodies-antibody-market-pepaxto-melphalan-flufenamide-melflufen-clinical-trials-fda-approved-oncology-cancer-peptide-clinical-pipeline “Global Peptide
Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024
"Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: • Commutative Market Opportunity During Initial 5 years of Commercialization: > US$ 2 Billion • Trispecific Antibodies In Clinical Trials: > 8 Antibodies • Highest Phase of Development: Phase I/II • Cancer Dominating Trispecific Antibodies Trials: > 5 Antibodies • Numab Therapeutics Dominating the Trispecific Development Pipeline • Prevention & Second Line Therapy Key Focus of Development of Trispecific Antibodies Download Report: https://www.kuickresearch.com/report-global-trispecific-antibodies-antibody-market-sales-size-companies-cancer-trispecific--clinical-trials-sar441236--development-conjugate-immunogenicity Trispecific cancer antibody therapy market at

All 5 Releases


More Releases for India

Medical Tour India | Affordable Treatment In India
We at MedCredible look after the well being of the patients seeking treatment in India. Our support staff support is well trained in handling various situations arising due to cross border differences. All the patients can avail of high-quality treatment at an extremely affordable cost in a compassionate environment combined with ethical practices. With options of over 100 + Hospitals and Institutions, we at Medcredible ensure that we connect the
01-17-2011 | Health & Medicine
KJIVF
IVF India, Test Tube baby India
The aim of setting up KJIVF is to help infertile couples in achieving conception through modern diagnostic and treatment methods. KJIVF Centre has given the best results by blessing infertile couples of advanced age with children, these couples could never dream of becoming parents. Thousands of babies are conceived through in-vitro fertilization (IVF) each year; In-Vitro Fertilization (IVF) means fertilization outside the body. A baby developed from an egg that
Beach Holiday India- Best Beaches in India
The natural beauty, exotic locations and rich heritage has helped India to stand as the most visited and most popular tourist spot in the world. The status of “Incredible India”, is defined by an incredible range of nature’s blessings on the Indian subcontinent and this incredibility is doubled by one of the most fabulous tourism option available in the country that are the brilliant and majestic beaches in India.
ISO 27001 India, 27001 training India ISO
Coral eSecure is information Risk Management advisory with specific focus on Information Security (ISO 27001, ISO 17799, PCI, COBIT, HIPAA, GLBA, and DPA), Business Continuity (BS25999) and ITIL/ IT Service Management (ISO 20000). Coral is the FIRST Indian consulting organization which provides an Integrated Management System Consulting, Consisting of ISO 27001, ISO 20000 and BS25999 – ALL THREE IN ONE! Coral provides Consulting, Assurance audit and Training to address these
Interior Designers India, Designers and Architects India
Today, we have recognized ourselves as a booming beauty interior designing firm, offering services that include interior designing. We are a winning firm, which is based on the strong foundation of innovative and original ideas for interior, architectural and landscaping designing services. Synergy Corporate Interior Design Association has more corporate members. Who provide Products and services. We support Interior Designers India, Designers and Architects India. We are committed to the
Domain Registration India, Web Hosting India, Payment Gateway India
Indiainternet.in is a Quality Web Hosting Company India, provide all web related support and Web hosting services like linux web hosting, windows web hosting, web hosting packages, domain registration in india, Corporate email solution, business email hosting, payment gateway integration, SSL with supports like free php, cgi, asp, free msaccess, free cdonts, free webmail, web based control panel, unlimited ftp access, unlimited data transfer. During the domain registration process, you will